anisodamine has been researched along with Shock, Septic in 28 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 16 (57.14) | 18.7374 |
| 1990's | 3 (10.71) | 18.2507 |
| 2000's | 2 (7.14) | 29.6817 |
| 2010's | 3 (10.71) | 24.3611 |
| 2020's | 4 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, L; Gao, Y; Hong, Y; Hu, C; Huang, Z; Liu, D; Ren, B; Tian, X; Wang, X; Yin, R; Yu, Y; Zhang, C; Zhang, Z; Zhou, J; Zhu, C | 1 |
| Anane, S; Attou, R; Barreto Gutierrez, L; Cismas, BV; De Bels, D; Gallerani, A; Honore, PM; Kaefer, K; Preseau, T; Redant, S | 1 |
| Jiang, W; Liu, Y; Ouyang, Z; Qiu, Y; Shen, J; Wan, F; Zeng, Y; Zhong, J | 1 |
| Chen, MZ; Deng, X; Dong, X; Guo, SB; Li, AJ; Lin, JH; Lin, ZF; Lin, ZH; Liu, JX; Mei, X; Shi, B; Tian, YP; Yuan, DS; Yuan, SY; Zha, JJ; Zhang, F; Zhang, L; Zhou, P | 1 |
| Su, H; Wang, H | 1 |
| Cai, GJ; Chen, AF; Kong, Y; Le, YY; Liu, C; Liu, X; Shen, FM; Su, DF | 1 |
| Lei, H; Li, Q; Liu, A; Liu, X; Su, D; Yang, Y | 1 |
| Liu, C; Liu, JG; Liu, Q; Su, DF; Sun, L; Zhang, GF; Zhang, X | 1 |
| Gong, P; Jiang, H; Liu, H; Zhang, Y; Zhao, GK | 1 |
| Chen, XY; Xi, PX; Yan, YZ | 2 |
| Chen, HC; Chen, L; Su, MC; Xu, SH | 1 |
| Chen, HH | 1 |
| Su, JY; Tang, C; Wu, L | 1 |
| Chen, HC; Wang, ZG; Xiao, DM | 1 |
| Dai, ZY; Sun, XY; Tong, HH; Xiao, YF; Xu, ZY; Yao, T; Yuan, M | 1 |
| Sun, RY | 1 |
| Coppo, PA; Hammerschmidt, DE; Jacob, HS; Xiu, RJ | 1 |
| Grantham, KD; Kelly, DR; Li, JX; Oliver, JR; Philips, JB | 1 |
| Cui, YH; Liu, YQ; Lun, N; Wang, BS; Wang, LZ; Zhu, FH | 1 |
| Xu, S | 1 |
| Shen, WT | 1 |
| Xiao, YF; Yao, T | 1 |
| Chen, HC; Wang, XL; Xiao, DM | 2 |
| Chen, HC; Tao, YP; Xiao, DM | 1 |
| Chen, HC; Wu, QX; Xu, SH | 1 |
| Chen, HC; Xiao, DM | 1 |
3 trial(s) available for anisodamine and Shock, Septic
| Article | Year |
|---|---|
Effectiveness of anisodamine for the treatment of critically ill patients with septic shock: a multicentre randomized controlled trial.
Topics: Critical Illness; Humans; Shock, Septic; Solanaceous Alkaloids; Treatment Outcome | 2021 |
Anisodamine hydrobromide in the treatment of critically ill patients with septic shock: a multicenter randomized controlled trial.
Topics: Critical Illness; Humans; Prospective Studies; Sepsis; Shock, Septic | 2023 |
[Effects of penehyclidine hydrochloride on the splanchnic perfusion of patients with septic shock].
Topics: Adult; Aged; Female; Humans; Male; Microcirculation; Middle Aged; Perfusion; Quinuclidines; Resuscitation; Shock, Septic; Solanaceous Alkaloids; Viscera | 2008 |
25 other study(ies) available for anisodamine and Shock, Septic
| Article | Year |
|---|---|
Anisodamine microcirulatory effects in septic shock: be aware of cardiac side effects.
Topics: Drug-Related Side Effects and Adverse Reactions; Heart; Humans; Shock, Septic; Solanaceous Alkaloids | 2021 |
Anisodamine hydrobromide attenuates oxidative stress and proinflammatory cytokines in septic rats induced by cecal ligation and puncture.
Topics: Animals; Atropine Derivatives; Cytokines; Disease Models, Animal; Interleukin-6; Ligation; Oxidative Stress; Punctures; Rats; Sepsis; Shock, Septic; Superoxide Dismutase; Tumor Necrosis Factor-alpha | 2022 |
[Reunderstanding and prospect of treatment of septic shock with anisodamine].
Topics: Drugs, Chinese Herbal; Humans; Shock, Septic; Solanaceous Alkaloids; Vasodilator Agents | 2015 |
Antishock effect of anisodamine involves a novel pathway for activating alpha7 nicotinic acetylcholine receptor.
Topics: Aconitine; alpha7 Nicotinic Acetylcholine Receptor; Animals; Base Sequence; Cell Line; China; DNA Primers; Interleukin-1beta; Macrophages, Peritoneal; Mice; Nicotinic Agonists; Nicotinic Antagonists; Polymerase Chain Reaction; Rats; Rats, Sprague-Dawley; Receptors, Nicotinic; Shock, Septic; Solanaceous Alkaloids; Tumor Necrosis Factor-alpha; Vagotomy | 2009 |
The antishock effect of anisodamine requires the upregulation of α7 nicotine acetylcholine receptors by IL-10.
Topics: Adrenergic alpha-Agonists; alpha7 Nicotinic Acetylcholine Receptor; Animals; Cells, Cultured; China; Cytokines; Dose-Response Relationship, Drug; Interleukin-10; Interleukin-1beta; Lipopolysaccharides; Mice; Mice, Inbred C57BL; Mice, Knockout; Receptors, Nicotinic; Shock, Septic; Solanaceous Alkaloids; Spleen; Survival Rate; Tumor Necrosis Factor-alpha; Up-Regulation | 2011 |
Combined administration of anisodamine and neostigmine produces anti-shock effects: involvement of α7 nicotinic acetylcholine receptors.
Topics: alpha7 Nicotinic Acetylcholine Receptor; Animals; Anti-Inflammatory Agents, Non-Steroidal; Cholinesterase Inhibitors; Dogs; Drug Therapy, Combination; Gene Knockout Techniques; Hemodynamics; Interleukin-1beta; Lipopolysaccharides; Liver; Mice; Mice, Knockout; Neostigmine; Receptors, Nicotinic; Shock, Hemorrhagic; Shock, Septic; Solanaceous Alkaloids; Survival Rate; Tumor Necrosis Factor-alpha; Vasodilator Agents | 2012 |
[Studies on the anti-shock mechanism of anisodamine. II. Dynamic change in blood histamine during endotoxic shock and effect of anisodamine on hypotensive effect of histamine].
Topics: Animals; Blood Pressure; Histamine; Rabbits; Shock, Septic; Solanaceous Alkaloids; Vasodilator Agents | 1983 |
[Effect of 5-HT and anisodamine in endotoxic shock].
Topics: Animals; Blood Platelets; Dogs; Platelet Count; Serotonin; Shock, Septic; Solanaceous Alkaloids | 1984 |
Large dose atropine alkaloids in the treatment of shock.
Topics: Adult; Atropine; Child; China; Humans; Injections, Intravenous; Scopolamine; Scopolamine Derivatives; Shock, Septic; Solanaceous Alkaloids | 1983 |
Experimental study in rabbits of the antishock effect of anisodamine (654-2), and its mechanism of action.
Topics: Animals; Blood Pressure; Male; Mesenteric Arteries; Mesenteric Vascular Occlusion; Peritonitis; Rabbits; Shock, Hemorrhagic; Shock, Septic; Solanaceous Alkaloids; Vasoconstrictor Agents | 1983 |
[Changes in the plasma levels of cyclic AMP and cyclic GMP in dogs with endotoxin shock and effects of anisodamine on these changes].
Topics: Animals; Cyclic AMP; Cyclic GMP; Dogs; Escherichia coli; Parasympatholytics; Shock, Septic; Solanaceous Alkaloids | 1983 |
Effects of anisodamine on cardiovascular activities in endotoxin-shocked dogs.
Topics: Animals; Blood Pressure; Cardiovascular System; Dogs; Female; Male; Myocardial Contraction; Shock, Septic; Solanaceous Alkaloids; Vascular Resistance; Vasodilator Agents | 1984 |
[Effects of anisodamine on pulmonary circulation and function of the dog in shock].
Topics: Animals; Dogs; Lung; Oxygen; Parasympatholytics; Pulmonary Circulation; Shock, Septic; Solanaceous Alkaloids | 1982 |
Anisodamine inhibits thromboxane synthesis, granulocyte aggregation, and platelet aggregation. A possible mechanism for its efficacy in bacteremic shock.
Topics: Animals; Cell Aggregation; Cricetinae; Depression, Chemical; Granulocytes; Humans; Ibuprofen; Platelet Aggregation; Scopolamine Derivatives; Shock, Septic; Solanaceous Alkaloids; Structure-Activity Relationship; Thromboxane B2; Thromboxanes; Vasodilator Agents | 1982 |
Effects of cholinergic blockade on hemodynamic disturbances and intestinal lesions in endotoxic shock in newborn piglets.
Topics: Analysis of Variance; Animals; Animals, Newborn; Blood Pressure; Carbon Dioxide; Cardiac Output; Diarrhea; Digestive System; Dose-Response Relationship, Drug; Endotoxins; Female; Heart Rate; Hemodynamics; Oxygen; Parasympatholytics; Partial Pressure; Pulmonary Artery; Shock, Septic; Solanaceous Alkaloids; Stroke Volume; Swine; Thromboxane B2; Time Factors; Tumor Necrosis Factor-alpha; Vascular Resistance; Vomiting | 1994 |
Effects of dexamethasone, cyproheptadine, anisodamine, and dinoprostone on TNF alpha production in endotoxic shock.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Cyproheptadine; Dexamethasone; Dinoprostone; Glucocorticoids; Liver; Male; Random Allocation; Rats; Rats, Wistar; RNA, Messenger; Shock, Septic; Solanaceous Alkaloids; Tumor Necrosis Factor-alpha | 1999 |
[A preliminary study of the inhibiting mechanism of anisodamine on rabbit platelets activated by E. coli endotoxin].
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Blood Platelets; Cyclic AMP; Endotoxins; Escherichia coli; Female; Male; Membrane Fluidity; Platelet Aggregation; Platelet Aggregation Inhibitors; Rabbits; Shock, Septic; Solanaceous Alkaloids | 1990 |
[Effect of anisodamine on serum beta-glucuronidase activity in shock].
Topics: Animals; Dogs; Drug Synergism; Female; Glucuronidase; Male; Shock, Septic; Solanaceous Alkaloids; Vasodilator Agents | 1985 |
[Cardiovascular effects of anisodamine during endotoxin shock in anaesthetized dogs].
Topics: Animals; Dogs; Female; Heart; Hemodynamics; Male; Shock, Septic; Solanaceous Alkaloids | 1986 |
[Experimental studies on the effect of anisodamine (654-2) on endotoxic shock].
Topics: Animals; Glucuronidase; Male; Mice; Neutrophils; Rabbits; Rats; Rats, Inbred Strains; Shock, Septic; Solanaceous Alkaloids | 1987 |
Inhibitory effects of anisodamine on endotoxin-induced prostaglandin production by cells in culture.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Cells, Cultured; Dinoprost; Female; Macrophages; Mice; Peritoneal Cavity; Shock, Septic; Solanaceous Alkaloids; Thromboxane B2 | 1988 |
[Changes in the plasma 6-keto-PGF1 alpha level during canine endotoxic shock].
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Blood Pressure; Dogs; Female; Male; Parasympatholytics; Platelet Aggregation; Shock, Septic; Solanaceous Alkaloids | 1985 |
Effects of anisodamine on plasma levels of thromboxane B2 (TXB2) and 6-keto-prostaglandin F1 alpha (6-keto-PGF1 alpha) in rat with septic shock.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Blood Pressure; Drugs, Chinese Herbal; Infusions, Intravenous; Male; Rats; Rats, Inbred Strains; Shock, Septic; Solanaceous Alkaloids; Thromboxane B2 | 1988 |
Anisodamine effects on functional and morphologic changes of platelets in endotoxinemic rabbits.
Topics: Animals; Blood Platelets; Female; Male; Platelet Aggregation; Rabbits; Shock, Septic; Solanaceous Alkaloids; Vasodilator Agents | 1985 |
Changes in the plasma levels of PGE, PGF2 alpha and 6-keto-PGF1 alpha in canine endotoxic shock.
Topics: 6-Ketoprostaglandin F1 alpha; Adolescent; Animals; Child; Child, Preschool; Dinoprost; Dogs; Epoprostenol; Female; Humans; Infant; Male; Prostaglandins E; Prostaglandins F; Shock, Septic; Solanaceous Alkaloids; Vasodilator Agents | 1985 |